By Jefferey Jaxen

For those who lived through the opening rounds of the COVID response, there is a familiar feeling as states and cities begin to line up to declare state of emergencies for the monkeypox outbreaks. 

On Monday, both California Gov. Gavin Newsom and Illinois Gov. J.B. Pritzker declared states of emergency in their states. On the same day, New York Mayor Eric Adams followed suit in “a move that lets him suspend local laws and enact new rulesto better manage the city’s outbreak” reports Politico. 

Cities may also be acting in alignment with some states as the San Diego Union-Tribune reported, Nathan Fletcher, chair of the San Diego County Board of Supervisors, was quick to signal that “we are likely to align with the state in the coming days by making our own declaration.”

It has become common knowledge that the monkeypox virus is nothing like the coronavirus – both in transmissibility and mutation rate. The states of emergency declarations allow individual states to coordinate the distribution vaccines, prevention efforts and to raise awareness about the issue while working to align with whatever the federal response looks like.

To date, no emergency federal response has been declared yet the Biden Administration has picked Robert Fenton, a regional administrator for FEMA to serve as the White House monkeypox coordinator. Meanwhile, the director of the Division of H.I.V. Prevention at the Centers for Disease Control and Prevention, Dr. Demetre Daskalakis, will serve as his deputy.

With a primary focus on vaccinations, the nation’s eyes now look to Bavarian Nordic’s Jynneos vaccine for answers. The U.S. government has invested a whopping $1B over the last decade to bolster a stockpile of Jynneos vaccine for this exact scenario, so what do we know about its effectiveness? 

 In an August 1 article by MedpageToday, the title reads How Well Does the Monkeypox Vax Work? No One Knows for Sure. 

Media outlets are throwing around the number of 85% effectiveness. Yet as MedpageToday states, that number “is based entirely on a small study done in Africa in the 1980s that has major limitations. One data expert calls its findings “pretty weak.” Other studies have only been conducted in animals.”

There are two inconvenient facts emerging during these declared emergencies concerning America’s highly-prized, billion dollar vaccine investment.

First, a major concern was voiced at the WHO meeting last week by Unit Head of Global Infectious Hazards Preparedness at the WHO Tim Nguyen, when he stated: 

“I would like to underline one thing that is very important to WHO. We do have uncertainties around the effectiveness of these vaccines because they haven’t been used in this context and this scale before. And therefore, we are working with our member states, that when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding on the effectiveness of these vaccines.” 

And second, in concurrence with Nguyen’s warning to the WHO, the CDC similarly states: “We do not know if JYNNEOS will fully protect against monkeypox virus infection in this outbreak. Individuals wanting to minimize their risk of infection should take additional preventive measures and self-isolate as soon as they develop monkeypox symptoms, such as a rash.”

While states step up prevention efforts and raise awareness to slow the spread of monkeypox, it seems like the Achilles’ heel, much like during the coronavirus outbreak, is the vaccine’s questionable effectiveness at stopping both transmission and infection.

The question on many people’s minds moving forward, after two years of societally-damaging lockdown restrictions imposed by public health officials and cheered on by experts in the media, is will they place restrictions on all of society in an attempt to slow the spread of monkeypox? 

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Study Finds Half of Adult ADHD Trials Lack Clear Diagnostic Standards

A new research review published by Cambridge University Press evaluated 292 random control trials (RCTs) studying Attention Deficit Hyperactive Disorder (ADHD) in adults and found that half of the studies do not use a clear diagnostic criterion to ensure participants have the condition. “Our finding that half of the RCTs exhibited little or no interestContinue reading New Study Finds Half of Adult ADHD Trials Lack Clear Diagnostic Standards

More news about Health & Nutrition

Vaccines

ACIP Votes 5–1 to Recommend Against Thimerosal in Flu Vaccines

The Advisory Committee on Immunization Practices (ACIP) recommended against influenza vaccines with Thimerosal as an adjuvant during the two-day meeting on Wednesday and Thursday. The CDC web page on Thimerosal in vaccines hasn’t been updated since December 2024 and states, “Thimerosal contains ethylmercury, which is cleared from the human body more quickly than methylmercury, andContinue reading ACIP Votes 5–1 to Recommend Against Thimerosal in Flu Vaccines

More news about Vaccines

Science & Tech

Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

Coinbase CEO Brian Armstrong declared his interest in creating a startup to work on gene-editing embryos, a type of editing that people say will lead to the creation of “designer babies.” CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been used in the medical field to help with certain conditions, and recently, a babyContinue reading Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

More news about Science & Tech

Environment

USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

The USDA is going to breed millions of flies, sterilize them with radiation, and send them into Texas and Mexico to prevent a re-emergence of the New World Screwworm(NWS), also known as a flesh-eating maggot. The NWS is endemic to Cuba, the Dominican Republic, and some South American countries, but it was eradicated in theContinue reading USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

More news about Environment

Policy

EPA Launches Lab Animal Adoption Program Amid Cuts to In-House Research

The EPA is now offering zebrafish and rats for private adoption that were formerly used by the agency in laboratory testing. The new program will eventually include rabbits and mice. The EPA announced in April, as reported by The HighWire, that it would phase out animal testing, along with the FDA. The latest announcement hasContinue reading EPA Launches Lab Animal Adoption Program Amid Cuts to In-House Research

More news about Policy